Peer Review History
| Original SubmissionAugust 6, 2025 |
|---|
|
-->PONE-D-25-42341-->-->Exploring the association between home delivery and under-five mortality in Ethiopia: A bivariate multilevel mixed-effects analysis-->-->PLOS ONE Dear Dr. Kassie, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 23 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Alfredo Luis Fort, M.D., M.Sc., Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments : I was about to invite reviewers but when looking at the manuscript, there were several errors and lack of clarity in the construction of phrases, that I have decided to send it back to you, the authors, to fully make it readable and have in checked by someone fully knowledgeable in English language. Please look in detail to all the comments and suggestions I have made in the attached file, and correct all the misinformation plus have it checked by someone fully skilled in written English academic language, before re-submitting. Thanks. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
-->PONE-D-25-42341R1-->-->Exploring the association between home delivery and under-five mortality in Ethiopia: A bivariate multilevel mixed-effects analysis-->-->PLOS One Dear Dr. Kassie, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Reviewers have raised some major issues in this manuscript. Comments related to methods are critical and need to be carefully and satisfactorily addressed. Authors need to explain why they used a different definition for under-five mortality and not following the conventional approach to this type of study. Issues around over-stating results and internal consistency need to be carefully addressed. ============================== Please submit your revised manuscript by Mar 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Emmanuel O Adewuyi, BPharm, MPH, PhD Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: N/A Reviewer #2: No ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: No Reviewer #2: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: No Reviewer #2: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: (No Response) Reviewer #2: Summary This manuscript investigates the association between home delivery and under-five mortality in Ethiopia using data from the 2019 Ethiopian Mini Demographic and Health Survey. The topic is highly relevant to maternal and child health in low- and middle-income countries, and the use of nationally representative data is a clear strength. The application of a bivariate multilevel mixed-effects model to jointly analyze two correlated outcomes is methodologically interesting and potentially valuable. However, several major issues require careful attention before the manuscript can be considered for publication. These relate mainly to causal interpretation, outcome definition, statistical clarity, internal consistency of results, and overinterpretation of findings. Addressing these concerns will substantially improve the scientific rigor and clarity of the manuscript. Major Comments 1. Causal interpretation and language Although the study uses a cross-sectional design, the manuscript frequently uses language that implies causality. Statements suggesting that home delivery increases under-five mortality, that home delivery is a significant risk factor, or that a specific proportion of under-five deaths is attributable to home delivery are not supported by the study design. Cross-sectional analyses can identify associations but cannot establish temporal order or causality, particularly for an outcome such as under-five mortality, which is influenced by many postnatal and contextual factors. The conclusions and several sections of the Results and Discussion should be revised to consistently use associative language. Home delivery should be described as being associated with higher odds of under-five mortality rather than as a causal determinant. 2. Definition and interpretation of under-five mortality Under-five mortality in this study is defined as a binary indicator reflecting whether a woman experienced at least one child death before age five. This differs from the standard definition of under-five mortality as deaths per 1,000 live births. While this operationalization may be analytically appropriate, it is not clearly or consistently communicated throughout the manuscript. In several places, percentages are reported in a way that may be misinterpreted as mortality rates. For example, statements indicating that under-five mortality was higher in rural residents expressed as percentages represent proportions of mothers reporting at least one child death rather than mortality rates. The manuscript should clearly emphasize that the unit of analysis is the mother rather than the individual child, that under-five mortality reflects maternal experience of child loss, and that reported percentages are proportions rather than rates. This clarification should be made explicit in the Methods, Results, and Discussion sections. 3. Statistical modeling clarity and transparency The statistical methods section contains extensive mathematical notation, but the conceptual explanation of the bivariate multilevel mixed-effects model is limited. It is not sufficiently clear how the joint model accounts for correlation between home delivery and under-five mortality, how the association parameter is interpreted in practical terms, or how random effects are specified across outcomes. The Results section also refers to concepts such as the loop rule without sufficient explanation in the Methods. In addition, the division of analytical tasks between STATA and R is not clearly described, which limits reproducibility. The manuscript would benefit from a clearer and more intuitive explanation of the modeling approach, a concise interpretation of the joint association parameter, and explicit information on which software and procedures were used for each analytical step. 4. Internal consistency and interpretation of results Several internal inconsistencies were noted across the manuscript. The reported chi-square statistics appear small relative to the extremely small p-value reported. Some findings related to antenatal care appear counterintuitive, particularly where lack of antenatal care is described as being associated with lower odds of home delivery, and these results are not adequately explained. In addition, intercepting terms from the multilevel model are interpreted substantively in a way that is not statistically appropriate. Intercepts represent baseline log odds under reference conditions and should not be interpreted as meaningful population-level effects. All statistical outputs should be carefully reviewed for consistency across tables and text, and interpretations should be revised to align with statistical meaning and epidemiological plausibility. 5. Magnitude and stability of regional effects Some regional adjusted odds ratios are extremely large, with values exceeding twenty in certain regions. These estimates raise concerns about sparse data, model instability, or overfitting. The manuscript does not provide sufficient information on regional sample sizes or event counts to assess the robustness of these findings. The authors should report sample sizes by region, discuss the possibility of sparse-data bias, and interpret large regional estimates with appropriate caution. Minor Comments 6. Organization and redundancy The Results section includes substantial interpretive content that overlaps with the Discussion. Reducing repetition and moving interpretation to the Discussion would improve clarity and structure. 7. Language and readability Although the manuscript has undergone language editing, minor grammatical issues and repetitive phrasing remain. Additional polishing would improve readability. 8. Figures and tables Figure 1 provides limited information beyond what is already presented in the tables and may be redundant. The authors may wish to reconsider its inclusion. 9. Terminology consistency Terminology related to under-five mortality should be used consistently throughout the manuscript to avoid ambiguity. Overall Recommendation Major revision The study addresses an important public health question and uses a potentially valuable analytical approach. However, substantial revisions are required to improve conceptual clarity, statistical transparency, consistency of interpretation, and alignment between the study design and the conclusions. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: Yes: Bayan Abuhalimeh Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 2 |
|
-->PONE-D-25-42341R2-->-->Exploring the association between home delivery and under-five mortality in Ethiopia: A bivariate multilevel mixed-effects analysis-->-->PLOS One Dear Dr. Kassie, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 10 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
--> If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Sajjad Haider Bhatti, Ph.D. Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Authors, I invite to revise your mansucript in light of the comments/concerns by reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #2: No Reviewer #3: Partly ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #2: No Reviewer #3: I Don't Know ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #2: Yes Reviewer #3: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #2: Yes Reviewer #3: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #2: Thank you to the authors for the revisions. While several aspects of the manuscript have improved, important concerns remain insufficiently addressed, particularly regarding causal interpretation, statistical validity, and consistency of interpretation. These issues need further revision before the manuscript can be considered for publication. Major Comments 1. Persistent causal language and overinterpretation Despite revisions, the manuscript continues to use causal language inconsistent with a cross-sectional design “implying causality”. Statements such as: • “children born at home are more likely to die” • “protective effect of institutional delivery” • “43% of deaths were attributed to home delivery” imply causality or attribution, which cannot be supported by the study design. The manuscript must consistently use associative language and avoid any implication of causation or attribution. 2. Inconsistency between outcome definition and interpretation The outcome is defined as a mother-level binary variable (experience of at least one under-five death). However, results and interpretations are frequently presented at the child level (e.g., “children born at home…”). This inconsistency is conceptually incorrect and must be resolved throughout the manuscript. 3. Statistical inconsistency in chi-square results The reported chi-square statistic (χ² = 3.83) with p < 0.0001 appears implausible and suggests either a reporting or calculation error. All statistical results should be carefully verified and corrected. 4. Continued misinterpretation of model intercepts The intercept term is still interpreted substantively. Intercepts represent baseline log-odds under reference conditions and should not be given epidemiological interpretation. 5. Limited improvement in statistical modeling clarity While the Methods section includes additional explanation, the model remains difficult to interpret. In particular: • the practical meaning of the association parameter is still unclear • the “loop rule” is referenced without sufficient explanation A more intuitive and applied explanation is needed. 6. Large regional effects remain insufficiently justified Although sample sizes are now provided, extremely large adjusted odds ratios (e.g., >20) remain concerning. The manuscript should: • discuss potential model instability more explicitly • consider sensitivity analyses or model diagnostics • interpret these estimates with greater caution Minor Comments • Some improvements in structure are noted, but minor language issues remain. • Terminology should be consistently aligned with the unit of analysis (mother vs child). • Thank you for incorporating the participant flow. It can be cosmetically improved by aligning the arrows. It should also show the ones that were excluded to be complete. Reviewer #3: The manuscript investigates an important public health issue using nationally representative Ethiopian DHS data and applies a useful bivariate multilevel modeling framework. The revised version has improved in terms of organization, terminology consistency, and reduction of causal language. The study has potential scientific value and contributes to understanding the association between home delivery and maternal experience of under-five mortality in Ethiopia. Some concerns still remain unaddressed. 1. Some interpretations continue to imply causality despite the cross-sectional design, particularly in the Discussion and Conclusion sections. 2. There are inconsistencies in the interpretation of ANC findings and the operational definition of under-five mortality, where mother-level outcomes are occasionally discussed as child-level mortality rates. 3. Regional odds ratios appear extremely large that suggest possible sparse-data bias or model instability, and these findings require more cautious interpretation. 4. The statistical methods section still needs simplification and clearer explanation of the bivariate multilevel framework. 5. Minor grammatical issues and repetitive statements are also present throughout the manuscript. 6. The study is relevant and methodologically interesting, but moderate revision is still required to improve statistical clarity, interpretation consistency, and overall readability before publication consideration. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. --> |
| Revision 3 |
|
Exploring the association between home delivery and under-five mortality in Ethiopia: A bivariate multilevel mixed-effects analysis PONE-D-25-42341R3 Dear Dr. Kassie, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sajjad Haider Bhatti, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-42341R3 PLOS One Dear Dr. Kassie, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sajjad Haider Bhatti Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .